# MRLinac Boost for Gynecological Cancers if Brachytherapy is Not Feasible (MARGARITA)

> **NCT05937958** · — · RECRUITING · sponsor: **UMC Utrecht** · enrollment: 30 (estimated)

## Conditions studied

- Cervical Cancer
- Gynecologic Cancer

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT05937958
- **Lead sponsor:** UMC Utrecht
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** RECRUITING
- **Start date:** 2023-04-01
- **Primary completion:** 2025-10-01
- **Final completion:** 2027-10-01
- **Target enrollment:** 30 (ESTIMATED)
- **Last updated:** 2023-07-18

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05937958

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05937958, "MRLinac Boost for Gynecological Cancers if Brachytherapy is Not Feasible (MARGARITA)". Retrieved via AI Analytics 2026-06-03 from https://api.ai-analytics.org/clinical/NCT05937958. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*